• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Institutional Review Board
  • UAMS Health
  • Jobs
  • Giving
  • About
    • Compliance Statement
    • Full Board Meetings
      • Committee Rosters
    • Institutional Review Board Blogs
    • Institutional Review Board Staff
    • Join the UAMS Institutional Review Board
    • Review Fees
  • CLARA
    • Access the System
    • Request a Human Subjects Research Determination
    • Start a Study
  • Templates, Training and Tools
    • Consent for Non-English Speakers
    • Events and Deviations Tables
    • Expanded Access Programs: Compassionate Use & Emergency Use
    • Human Subject Protection Training Instructions
  • Reporting to the Institutional Review Board
  • Expanded Access
  • Institutional Review Board Policies
    • Current Institutional Review Board Policies
      • 1 Principles and Authority
      • 2 Relationships
      • 3 Committee Membership
      • 4 Institutional Review Board Operations
      • 5 Records (Retired)
      • 6 Documentation
      • 7 Procedures for Study Review
      • 8 Change in Protocol
      • 9 Institutional Review Board Decisions
      • 10 Principal Investigator Responsibilities
      • 11 Appeals and Reconsiderations (retired)
      • 12 Quality Assurances
      • 13 Confidentiality
      • 14 Recruitment Practices
      • 15 Consent
      • 16 Risk / Benefit Analysis (moved)
      • 17 Special Populations
      • 18 Drugs and Devices
      • 19 Human Genetics Guidance
      • 20 Questions, Concerns, Suggestions and Complaints
    • Institutional Review Board Policy Archives
      • 1 Principles and Authority Archive
      • 2 Relationships Archive
      • 3 Committee Membership Archive
      • 4 Institutional Review Board Operations Archive
      • 5 Records Archive
      • 6 Documentation Archive
      • 7 Procedures for Study Review Archive
      • 8 Change in Protocol Archive
      • 9 Institutional Review Board Decisions Archive
      • 10 Principal Investigator Responsibilities Archive
      • 11 Appeals and Reconsiderations Archive
      • 12 Quality Assurances Archive
      • 13 Confidentiality Archive
      • 14 Recruitment Practices Archive
      • 15 Consent Archive
      • 16 Risk / Benefit Analysis Archive
      • 17 Special Populations Archive
      • 18 Drugs and Devices Archive
      • 19 Human Genetics Guidance Archive
      • 20 Questions, Concerns, Suggestions, Complaints Archive
  • Research Resources
    • Acronyms and Resources
    • FAQs
      • CITI Program FAQs
      • CLARA FAQs
      • Does my project need IRB review?
      • Prereview and Review Process FAQs
      • Reporting FAQs
      • Submission FAQs
    • Single / Central Institutional Review Board Review
  • Human Research Protection Program Plan
  1. University of Arkansas for Medical Sciences
  2. Research and Innovation
  3. Institutional Review Board
  4. It’s (almost) official — Revised Common Rule likely to be delayed again

It’s (almost) official — Revised Common Rule likely to be delayed again

You may recall that in January, the federal Department of Health and Human Services (HHS) announced a 6-month delay in the implementation of the Revised Common Rule. Part of the intent of that delay was to allow stakeholders to formally request a longer delay.

Well, we’re now one step closer to that longer delay period. HHS and other federal agencies under the rule have released a new Notice of Proposed Rulemaking (NPRM), seeking comment on a proposal to move the implementation date to January 21, 2019, instead of the current July 2018 date. The comment period for the NPRM runs through May 20.

The NPRM also proposes allowing institutions to implement three aspects of the revised rule during the delay period, because these changes are considered burden-reducing. Those three changes are:**

  1. use of the revised definition of “research,” which deems four categories of activities as not research (not much will change for UAMS/ACH researchers in this regard, as these four categories don’t really apply to what we do here)
  2. allowance for no annual continuing review for certain categories of research (fingers crossed — many PIs may like the idea of not having annual continuing however)
  3. elimination of the requirement for IRB review of grant applications for research (this would mean one less thing to upload in the CLARA file and one less thing for the IRB to review).

**Please note that changes 1 and 3 would have only minimal impact on researchers’ IRB interactions, and we’re not sure yet if we’re going to entirely do away with annual continuing review for low-risk non-exempt studies. Institutions can add requirements in addition to what the Common Rule specifies, and there may be institutional reasons to keep some sort of regular check-in with investigators on the table.  Institutions may also have the option of continuing under the current rule until the new rule is fully implemented.

And yes, this on-again, off-again revision of the Common Rule is driving us all a little crazy. The joke in the IRB office is that we should comment that we hope the final implementation of the rule is delayed until after we’re all retired. It has taken years to get us this far, so why not add a few more more years to the wait, right? Please read this blog item on the Public Responsibility in Medicine and Research website for more information on what its author calls “the rather tortured path” of the revised rule.

Posted by Edith Paal on April 23, 2018

Filed Under: Institutional Review Board Members

University of Arkansas for Medical Sciences LogoUniversity of Arkansas for Medical SciencesUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Legal Notices

© 2025 University of Arkansas for Medical Sciences